HBEAG LOSS INCIDENCE RATE DECLINED SHARPLY AFTER FIRST YEAR IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUE THERAPY

Peng, CW; Jeng, WJ; Chien, RN; Liaw, YF

HEPATOLOGY, 2019; 70 (): 315A